Journal for ImmunoTherapy of Cancer Issues Research Articles in March 2024 Edition
March 15, 2024
March 15, 2024
MILWAUKEE, Wisconsin, March 15 -- The Journal for ImmunoTherapy of Cancer, a peer-reviewed journal from the Society for Immunotherapy of Cancer that says it features all aspects of tumor immunology and cancer immunotherapy, published research articles on the following topics in its March 2024 edition:
Basic tumor immunology:
* Original research: BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1
* Original research: Cancer-oocyte SAS1B protein . . .
Basic tumor immunology:
* Original research: BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1
* Original research: Cancer-oocyte SAS1B protein . . .